Correlation Between Ondine Biomedical and Schroder

Can any of the company-specific risk be diversified away by investing in both Ondine Biomedical and Schroder at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ondine Biomedical and Schroder into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Ondine Biomedical and Schroder UK Mid, you can compare the effects of market volatilities on Ondine Biomedical and Schroder and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ondine Biomedical with a short position of Schroder. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ondine Biomedical and Schroder.

Diversification Opportunities for Ondine Biomedical and Schroder

0.45

Correlation Coefficient

Ondine Biomedical  Schroder

Very weak diversification

The 3 months correlation between Ondine and Schroder is 0.45. Overlapping area represents the amount of risk that can be diversified away by holding Ondine Biomedical and Schroder UK Mid in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Schroder UK Mid and Ondine Biomedical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ondine Biomedical are associated (or correlated) with Schroder. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Schroder UK Mid has no effect on the direction of Ondine Biomedical i.e., Ondine Biomedical and Schroder go up and down completely randomly.

Pair Corralation between Ondine Biomedical and Schroder

Assuming the 90 days trading horizon Ondine Biomedical is expected to generate 3.98 times more return on investment than Schroder. However, Ondine Biomedical is 3.98 times more volatile than Schroder UK Mid. It trades about 0.15 of its potential returns per unit of risk. Schroder UK Mid is currently generating about 0.05 per unit of risk. If you would invest  800.00  in Ondine Biomedical on November 27, 2024 and sell it today you would earn a total of  325.00  from holding Ondine Biomedical or generate 40.63% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	98.39%
Values	Daily Returns

Ondine Biomedical  vs.  Schroder UK Mid

Ondine Biomedical

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Ondine Biomedical are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of rather uncertain technical and fundamental indicators, Ondine Biomedical exhibited solid returns over the last few months and may actually be approaching a breakup point.

Schroder UK Mid

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Schroder UK Mid are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of rather sound technical and fundamental indicators, Schroder is not utilizing all of its potentials. The newest stock price tumult, may contribute to shorter-term losses for the shareholders.

Pair Trading with Ondine Biomedical and Schroder

The main advantage of trading using opposite Ondine Biomedical and Schroder positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ondine Biomedical position performs unexpectedly, Schroder can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Schroder will offset losses from the drop in Schroder's long position.

The idea behind Ondine Biomedical and Schroder UK Mid pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.